2009Zhiye yu jiankangRequires access

Clinical Analysis on Alprostadil Combined with Mecobalamin for Diabetic Peripheral Neuropathy

Haiyan Yu

Open publisher page 1 citations

Abstract

[Objective]To observe the therapeutic effects of alprostadil combined with mecobalamin for diabetic peripheral neuropathy.[Methods]100 patients with diabetic peripheral neuropathy were randomly divided into control group(mecobalamine intramuscular injection) and treatment group(alprostadil intravenous drip on the basis of control group treatment).After 2 weeks,the therapeutic effects were compared between the two groups.[Results][Results]There was significant difference in the total effective rate of improving clinical symptoms between treatment group(90%) and control group(64%)(P0.01).The peripheral nerve conduction velocity in two groups all had improved,but that in treatment group was better than that in control group significantly(P0.05).[Conclusion][Conclusion]Alprostadil combined with mecobalamin can improve the curative effect of diabetic peripheral neuropathy obviously.

About this research paper

What this paper is about

[Objective]To observe the therapeutic effects of alprostadil combined with mecobalamin for diabetic peripheral neuropathy.[Methods]100 patients with diabetic peripheral neuropathy were randomly divided into control group(mecobalamine intramuscular injection) and treatment group(alprostadil intravenous drip on the basis of control group treatment).After 2 weeks,the therapeutic effects were compared between the two groups.[Results][Results]There was significant difference in the total effective rate of improving clinical symptoms between treatment group(90%) and control group(64%)(P0.01).The peripheral nerve conduction velocity in two groups all had improved,but that in treatment group was better than that in control group significantly(P0.05).[Conclusion][Conclusion]Alprostadil combined with mecobalamin can improve the curative effect of diabetic peripheral neuropathy obviously.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective]To observe the therapeutic effects of alprostadil combined with mecobalamin for diabetic peripheral neuropathy.[Methods]100 patients with diabetic peripheral neuropathy were randomly divided into control group(mecobalamine intramuscular injection) and treatment group(alprostadil intravenous drip on the basis of control group treatment).After 2 weeks,the therapeutic effects were compared between the two groups.[Results][Results]There was significant difference in the total effective rate of improving clinical symptoms between treatment group(90%) and control group(64%)(P0.01).The peripheral nerve conduction velocity in two groups all had improved,but that in treatment group was better than that in control group significantly(P0.05).[Conclusion][Conclusion]Alprostadil combined with mecobalamin can improve the curative effect of diabetic peripheral neuropathy obviously.

Key concepts: Medicine, Peripheral neuropathy, Peripheral, Nerve conduction velocity, Therapeutic effect, Diabetic neuropathy, Anesthesia, Intramuscular injection

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Analysis on Alprostadil Combined with Mecobalamin for Diabetic Peripheral Neuropathy — Research Paper | ScholarLens